Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SPH North Pharmaceutical is a prominent subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., located in the Benxi High-tech Industrial Development Zone, often referred to as China Medicine Capital. The company serves as a strategic manufacturing and R&D hub for Shanghai Pharma in Northern China, focusing on a broad portfolio of chemical drug preparations and traditional Chinese medicines (TCM). Its facilities are GMP-certified and equipped for large-scale production of tablets, capsules, and injections. The company is particularly recognized for its work in cardiovascular and cerebrovascular health, as well as metabolic and digestive treatments. By integrating modern pharmaceutical technology with traditional formulations, SPH North Pharmaceutical plays a critical role in the parent company's domestic supply chain and regional market expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SPH (Benxi) North Pharmaceutical.